PriceTargets.com logo

NASDAQ:HSTM - HealthStream Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $30.00
  • Forecasted Upside: 20.39 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$24.92 As of 12/8/2021 01:00 AM ET
▲ +0.21 (0.85%)

This chart shows the closing price for HSTM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New HealthStream Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HSTM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HSTM

Analyst Price Target is $30.00
▲ +20.39% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for HealthStream in the last 3 months. The average price target is $30.00, with a high forecast of $36.00 and a low forecast of $24.00. The average price target represents a 20.39% upside from the last price of $24.92.

This chart shows the closing price for HSTM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 contributing investment analysts is to hold stock in HealthStream. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/13/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
3/13/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/11/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/9/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/8/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/28/2021Barrington ResearchReiterated RatingMarket PerformLow
7/28/2021Craig HallumBoost Price TargetBuy$30.00 ➝ $36.00Medium
4/28/2021Canaccord GenuityBoost Price TargetHold$22.00 ➝ $24.00Medium
2/25/2021Canaccord GenuityReiterated RatingHold$22.00Low
2/24/2021Cantor FitzgeraldReiterated RatingNeutralLow
2/24/2021Raymond JamesReiterated RatingHoldHigh
2/23/2021William BlairReiterated RatingOutperformHigh
12/1/2020Canaccord GenuityReiterated RatingHold$20.00High
10/28/2020Canaccord GenuityReiterated RatingHold$24.00 ➝ $20.00High
8/17/2020Barrington ResearchUpgradeHoldLow
7/29/2020Canaccord GenuityReiterated RatingHold$24.00Low
7/23/2020Barrington ResearchReiterated RatingHoldLow
4/29/2020Canaccord GenuityReiterated RatingHold$25.00Medium
3/11/2020Barrington ResearchReiterated RatingHoldHigh
2/20/2020Canaccord GenuityReiterated RatingHold$28.00Medium
12/19/2019Raymond JamesInitiated CoverageMarket PerformLow
7/25/2019Barrington ResearchReiterated RatingMarket PerformMedium
4/24/2019Barrington ResearchReiterated RatingHoldMedium
2/19/2019Cantor FitzgeraldReiterated RatingHold$26.00High
2/19/2019Barrington ResearchReiterated RatingHoldLow
1/14/2019Barrington ResearchReiterated RatingHoldLow
12/6/2018Barrington ResearchReiterated RatingHoldHigh
10/23/2018Barrington ResearchReiterated RatingHoldLow
10/17/2018Barrington ResearchReiterated RatingHoldHigh
7/25/2018Barrington ResearchReiterated RatingHoldHigh
7/23/2018Canaccord GenuityReiterated RatingHold$26.00High
7/23/2018Cantor FitzgeraldReiterated RatingHold$25.00High
7/18/2018Barrington ResearchReiterated RatingHoldLow
7/11/2018Barrington ResearchDowngradeOutperform ➝ Market Perform$30.00Low
6/20/2018Robert W. BairdDowngradeOutperform ➝ Neutral$24.00Low
6/14/2018Robert W. BairdDowngradeOutperform ➝ Neutral$28.00High
5/3/2018Barrington ResearchSet Price TargetBuy$32.00High
5/2/2018Canaccord GenuityReiterated RatingHold$26.00High
4/26/2018Barrington ResearchReiterated RatingBuy$32.00Low
2/26/2018Barrington ResearchReiterated RatingBuy$32.00Low
2/13/2018William BlairReiterated RatingOutperformLow
2/12/2018Cantor FitzgeraldReiterated RatingHold$24.00Low
10/25/2017Robert W. BairdLower Price TargetOutperform$30.00 ➝ $28.00N/A
10/25/2017Needham & Company LLCDowngradeBuy ➝ HoldN/A
10/24/2017Needham & Company LLCReiterated RatingBuy ➝ Hold$26.00N/A
10/23/2017Canaccord GenuityReiterated RatingHold$25.00N/A
8/31/2017Robert W. BairdReiterated RatingBuy$30.00Low
7/27/2017Canaccord GenuityReiterated RatingHold$25.00Low
7/26/2017Cantor FitzgeraldReiterated RatingNeutral$28.00 ➝ $24.00Medium
7/26/2017Needham & Company LLCLower Price TargetBuy$32.00 ➝ $26.00Low
7/26/2017First AnalysisUpgradeUnderweight ➝ Equal Weight$19.00Low
6/27/2017Robert W. BairdReiterated RatingOutperform$35.00Low
5/1/2017Cantor FitzgeraldBoost Price TargetNeutral$27.00 ➝ $30.00Low
4/26/2017Needham & Company LLCBoost Price TargetBuy$28.00 ➝ $32.00High
4/25/2017Craig HallumUpgradeHold ➝ BuyHigh
4/25/2017Robert W. BairdSet Price TargetBuy$31.00High
2/23/2017Needham & Company LLCReiterated RatingBuy$28.00N/A
2/22/2017Cantor FitzgeraldReiterated RatingNeutral$27.00N/A
2/17/2017Canaccord GenuityReiterated RatingNeutral ➝ Hold$24.00N/A
1/23/2017First AnalysisDowngradeEqual Weight ➝ Underweight$24.00 ➝ $18.00N/A
1/13/2017Canaccord GenuityReiterated RatingHold$24.00N/A
1/5/2017Cantor FitzgeraldInitiated CoverageNeutral$27.00N/A
1/3/2017Canaccord GenuityReiterated RatingHold$24.00N/A
(Data available from 12/9/2016 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/13/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/12/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/12/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/11/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/10/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/10/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/9/2021
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/9/2021

Current Sentiment

  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

HealthStream logo
HealthStream, Inc. engages in the provision of services to healthcare organizations. It operates through the following segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment offers training, certification, assessment, development, and scheduling needs of the healthcare workforce. The Provider Solutions delivers software applications for administering and tracking provider credentialing, privileging, call center, and enrollment activities. The company was founded by Robert A. Frist, Jr. and Jeffery L. McLaren in 1990 and is headquartered in Nashville, TN.
Read More

Today's Range

Now: $24.92
Low: $24.40
High: $25.01

50 Day Range

MA: $26.71
Low: $23.22
High: $29.23

52 Week Range

Now: $24.92
Low: $20.02
High: $31.11

Volume

39,065 shs

Average Volume

97,016 shs

Market Capitalization

$786.53 million

P/E Ratio

108.35

Dividend Yield

N/A

Beta

0.37

Frequently Asked Questions

What sell-side analysts currently cover shares of HealthStream?

The following Wall Street sell-side analysts have issued stock ratings on HealthStream in the last year: Barrington Research, Canaccord Genuity, Cantor Fitzgerald, Craig Hallum, Raymond James, William Blair, and Zacks Investment Research.
View the latest analyst ratings for HSTM.

What is the current price target for HealthStream?

2 Wall Street analysts have set twelve-month price targets for HealthStream in the last year. Their average twelve-month price target is $30.00, suggesting a possible upside of 20.4%. Craig Hallum has the highest price target set, predicting HSTM will reach $36.00 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of $24.00 for HealthStream in the next year.
View the latest price targets for HSTM.

What is the current consensus analyst rating for HealthStream?

HealthStream currently has 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HSTM, but not buy more shares or sell existing shares.
View the latest ratings for HSTM.

What other companies compete with HealthStream?

Other companies that are similar to HealthStream include Cerner, Omnicell, Allscripts Healthcare Solutions, Vocera Communications, Computer Programs and Systems, Cortexyme, Athena Technology Acquisition and Mirage Energy.

How do I contact HealthStream's investor relations team?

HealthStream's physical mailing address is 500 11TH AVENUE NORTH SUITE 1000, NASHVILLE TN, 37203. The technology company's listed phone number is (615) 301-3100 and its investor relations email address is [email protected] The official website for HealthStream is www.healthstream.com.